Editorial notice: TotalCareMedical.com is an independent health and wellness research publication. This review is for educational and informational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs that require evaluation, prescription, and monitoring by a licensed healthcare professional. Compounded medications discussed here have not been reviewed or approved by the FDA for safety, effectiveness, or quality. Eligibility is determined by a licensed clinician. Some links on this page may be affiliate links — see our full disclosure for details. Pricing and program terms are based on publicly available information from the official Wellorithm website and are subject to change.
What Is Wellorithm?
Wellorithm is a telehealth weight management platform that connects patients with licensed U.S. clinicians for evaluation and, when a clinician determines it is medically appropriate, prescription access to compounded GLP-1 medications. The program operates through a three-entity structure standard across this category of service: Wellorithm is the technology platform, clinical decisions belong to independent licensed providers, and medications are dispensed by licensed U.S. pharmacy partners. These are three distinct functions operating under separate regulatory frameworks.
This review examines what Wellorithm actually offers — the verified medication options, the pricing and refund terms as published, the compounding distinction and regulatory context, the program structure, and what questions to confirm before enrolling. For a step-by-step explanation of how the platform process works, see our how Wellorithm works explainer. For a full breakdown of the semaglutide pathway specifically, see our Wellorithm semaglutide breakdown.
What Wellorithm Offers: Medication Options
According to the official Wellorithm website, the program offers four compounded medication pathways — all prescription-only and subject to clinician evaluation:
Compounded Semaglutide Injection: A once-weekly injectable formulation. Semaglutide is a GLP-1 receptor agonist — the active ingredient in FDA-approved brand-name products Wegovy and Ozempic. The compounded version is not an FDA-approved finished product.
Compounded Tirzepatide Injection: A once-weekly injectable formulation. Tirzepatide is a dual GLP-1/GIP receptor agonist — the active ingredient in FDA-approved Zepbound and Mounjaro. The compounded version is not an FDA-approved finished product.
Compounded Semaglutide Oral Dissolving Tablets: An oral formulation for patients for whom injectables are not preferred, subject to clinician evaluation.
Compounded Tirzepatide Oral Dissolving Tablets: An oral tirzepatide formulation, also subject to clinician evaluation and prescribing appropriateness.
As Wellorithm's own website states: compounded medications have not been reviewed or approved by the FDA for safety, effectiveness, or quality. The prescribing clinician makes the determination of whether any of these options is appropriate for each individual patient based on their health profile and medical history.
Pricing: Verified Published Terms
According to the official Wellorithm website, published starting prices are as follows: compounded semaglutide starts at $147; compounded tirzepatide starts at $249.
These are starting prices. Actual costs depend on the dosage level prescribed and the specific plan selected. The program is billed on a recurring 28-day cycle. Wellorithm operates on a cash-pay model — insurance is generally not billed directly. Coverage or reimbursement, if any, depends on your individual insurance plan; confirm with your insurer before enrolling.
These figures were published on the official Wellorithm website at the time this review was prepared. Pricing is subject to change without notice. Always verify current pricing directly on the official Wellorithm website before making an enrollment decision.
Refund Policy: What the Published Terms Say
Per Wellorithm's published terms of service: membership payments are non-refundable once processed. Patients may cancel at any time by contacting the support team via email. There is no published unconditional money-back guarantee. This is a meaningful distinction from some competitors in this space who publish conditional weight-loss guarantees — Wellorithm's published terms do not include such a guarantee as of the time this review was prepared.
Before enrolling in any recurring-billing subscription program, understanding the cancellation and refund terms is a basic consumer protection step. Verify the current published terms directly on the official Wellorithm website or with the support team before providing payment information.
The Compounding Distinction: What It Means
This is the most important concept to understand before evaluating any compounded GLP-1 telehealth program.
FDA-approved brand-name GLP-1 products — Wegovy and Ozempic (semaglutide), Zepbound and Mounjaro (tirzepatide) — are finished drug products that have undergone the FDA's comprehensive drug approval process: clinical trials, manufacturing quality standards, potency and stability testing, and ongoing post-market surveillance. They are produced by their respective pharmaceutical manufacturers under FDA oversight.
Compounded semaglutide and tirzepatide are prepared by licensed compounding pharmacies based on individual patient prescriptions. The finished compounded products have not undergone the same FDA approval process. They contain the same active pharmaceutical ingredients as the brand-name drugs, but they are legally and regulatorily distinct products. Compounding pharmacies operate under state pharmacy law and applicable federal compounding statutes, which set different manufacturing standards than the FDA drug approval pathway.
Additionally, the legal framework for compounded GLP-1 medications in 2026 has been directly tied to FDA drug shortage designations — a regulatory context that has been actively evolving for both semaglutide and tirzepatide. Patients should confirm the current availability and regulatory standing of compounded GLP-1 medications through any specific platform before enrolling. This is not a static situation.
The Three-Entity Structure: Platform, Clinician, Pharmacy
Understanding how Wellorithm is organized clarifies what you are actually getting when you enroll. Wellorithm is the technology platform — it manages the intake process, connects patients with clinicians, coordinates with pharmacy partners, and provides the support infrastructure. The clinical decisions — including whether to prescribe, what to prescribe, and at what dose — belong to the independent licensed clinicians who conduct the evaluations. The medications are dispensed by licensed U.S. compounding pharmacies that are separate from both Wellorithm and the clinical providers.
This structure is standard across the telehealth weight management category and ensures appropriate legal separation between coordination, clinical decision-making, and medication dispensing. It also means that Wellorithm itself does not make prescribing decisions — those belong to the clinician who reviews your case.
Program Structure: What Wellorithm Describes
Wellorithm describes a four-stage process: a 2-minute online intake quiz to begin the approval process, a virtual consultation with a licensed clinician, a personalized plan and medication dispensed through a licensed pharmacy, and ongoing monitoring and support. The platform states that support is available 24 hours a day, seven days a week, by phone at +1 (877) 402-6778. Virtual consultations are conducted via video appointment scheduled to fit the patient's schedule, according to the official website.
GLP-1 medications require ongoing monitoring — dose titration, side effect assessment, and follow-up evaluation. A well-structured telehealth program includes these touchpoints rather than functioning as a one-time prescription service. Patients evaluating Wellorithm should confirm what follow-up is included in the program pricing and how ongoing monitoring is handled after the initial prescription.
Coverage: States Served
Per Wellorithm's published FAQ, the platform serves 49 U.S. states. Louisiana is currently excluded. Services are not available outside the United States. Confirm state availability directly with Wellorithm before beginning the intake process.
How Wellorithm Compares to the Category
The compounded GLP-1 telehealth space has expanded significantly heading into 2026. Wellorithm's published starting prices — $147 for semaglutide, $249 for tirzepatide — are at the lower end of published pricing for compounded GLP-1 programs in this category. For context, comparable platforms in the same category typically publish starting prices ranging from $147 to $350 or higher for compounded semaglutide, with tirzepatide programs generally priced higher than semaglutide across the category.
Price alone is not a reliable indicator of program quality. The relevant evaluation dimensions include: the clinical intake process and provider qualifications, the pharmacy sourcing and compounding compliance, what ongoing monitoring and follow-up are included, and the refund and cancellation terms. For a side-by-side evaluation of Wellorithm against other platforms in this category, see our Wellorithm vs. competitors comparison. For platform reviews of comparable services, see TeleHealth Med and SynergyRx GLP-1.
What to Confirm Before You Enroll
Before enrolling in Wellorithm or any compounded GLP-1 telehealth program, these are the questions worth confirming directly with the platform or your healthcare provider.
Is the specific compounded medication currently available in your state under the current regulatory framework? Is Wellorithm currently serving your state? What is the all-in pricing for the specific medication and dosage you are likely to be prescribed — the starting price reflects the lowest tier? What pharmacy will dispense the medication, and what is that pharmacy's compounding compliance status? What monitoring and follow-up is included after the initial prescription, and is that covered in the published price? What are the exact cancellation and refund terms currently in effect?
For a full breakdown of potential side effects and safety considerations, see our Wellorithm side effects breakdown. For a full overview of how the program process works from intake to delivery, see our how Wellorithm works explainer. For a complete index of GLP-1 telehealth platform reviews on this site, visit our telehealth platform reviews hub.
Frequently Asked Questions
Is Wellorithm a legitimate telehealth service? Wellorithm is a telehealth platform that connects patients with licensed U.S. clinicians and licensed pharmacy partners for compounded GLP-1 evaluation and, when prescribed, medication delivery. The medications offered are compounded formulations that have not been reviewed or approved by the FDA for safety, effectiveness, or quality. Whether the platform is appropriate for a specific individual depends on clinical factors evaluated by a licensed provider.
How much does Wellorithm cost? According to the official Wellorithm website, compounded semaglutide starts at $147 and compounded tirzepatide starts at $249. These are starting prices — actual costs depend on dosage and plan. Membership is billed on a recurring 28-day cycle. Payments are non-refundable once processed. Verify current pricing directly on the official website before enrolling.
Does Wellorithm offer a money-back guarantee? Per Wellorithm's published terms, membership payments are non-refundable once processed. Patients can cancel at any time by contacting the support team via email. There is no published unconditional money-back guarantee. Verify current refund terms directly with Wellorithm before enrolling.
What states does Wellorithm serve? Per Wellorithm's published FAQ, the platform serves 49 U.S. states. Louisiana is currently excluded. Services are not available outside the United States. Confirm state availability directly with Wellorithm before enrolling.
What is the difference between compounded and brand-name GLP-1 medications? FDA-approved brand-name GLP-1 products — such as Wegovy and Ozempic (semaglutide) and Zepbound and Mounjaro (tirzepatide) — have been reviewed by the FDA for safety, efficacy, and manufacturing quality as finished products. Compounded GLP-1 medications are prepared by licensed pharmacies based on individual prescriptions and have not undergone the same FDA approval process. Both contain the same active ingredients, but their regulatory status and manufacturing quality standards differ.
How do I contact Wellorithm? Per the official Wellorithm website, the support team is available 24 hours a day, seven days a week, by phone at +1 (877) 402-6778 and by email at contact@wellorithm.com.